MedTrace Logo

Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance

NCT03648359 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-09-12

No results posted yet for this study

Summary

To investigate whether multiparametric MRI (mp-MRI) in patients with low-risk prostate cancer can improve the selection of patients suitable for Active Surveillance and have a relevance in the ongoing monitoring

Conditions

  • Prostatic Neoplasms

Interventions

PROCEDURE

multiparametric MRI Diagnostics

Patients with newly diagnosed prostate cancer enrolled in active surveillance following standard protocol including PSA, DRE and TRUS biopsies and intervention with multiparametric MRI + additional biopsies if suspicious lesions are found

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Lars Boesen, MD, PhD · Department of Urology, Herlev University Hospital Herleb, Herlev, Denmark, 2730

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648359 on ClinicalTrials.gov